A recent study carried out by a research team from the Paul-Ehrlich-Institut investigated the immunomodulating properties of ...

Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could ...

R.F.K. Jr. and others have blamed the ingredient for allergies and other illnesses. Scientists say it actually bolsters the ...

Global Vaccine Adjuvants Market size is expected to be worth around USD 1289.0 Million by 2023 from USD 3,933.7 Million in 2032, growing at a CAGR of 13.6% The Research Segment Is The Fastest ...

SaponiQx, a leader in saponin-based adjuvant discovery, is pleased to announce a strategic collaboration with Probius, a pioneer in quantum molecular ...

January 28, 2025 - Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that ...

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...

Kennedy could be entirely wrong about everything he has ever said about vaccines and still claim a better record on health issues than all the ...